Zerion APS

ZERION has is a pharmaceutical development company established as a spinout form the University of Copenhagen in 2019. ZERION has pioneered the Dispersome® technology that is addressing one of the most challenging problems in pharmaceutical development: poor solubility of small molecule drugs. By formulating insoluble small molecule APIs with novel protein-based excipients into amorphous dispersions, dramatic increases in solubility and corresponding bioavailability are achievable.


Contact name:

Ole Wiborg


Blokken 11, 3460 Birkerød, Denmark





Number of employees:


If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact ps@danskbiotek.dk or +45 7172 1114

Copyright 2019 DANISH BIO – DANSK BIOTEK. All rights reserved.